Company intelligence / Profile preview

Aesica Queenborough Limited

Queenborough, Kent, United Kingdom

Ownership: Private
Employees: ~277
Development stage: Other

Overview

Aesica Queenborough Limited was a CDMO/CMO acquired from Abbott Laboratories in September 2007. Its Queenborough facility specialized in manufacturing high potent APIs, controlled substances, and solid/liquid dosage forms, and was FDA approved in 2012. The company is no longer active, with recent activity noting liquidation status.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Abbott Laboratories (historical supply agreement)

Beyond the preview

Go deeper on Aesica Queenborough Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aesica Queenborough Limited.

Explore the full profile